Intensive versus moderate atorvastatin therapy and one-year graft patency after CABG: Rationale and design of the ACTIVE (Aggressive Cholesterol Therapy to Inhibit Vein Graft Events) randomized controlled trial (NCT01528709)
2017 ◽
Vol 59
◽
pp. 98-104
◽
2010 ◽
Vol 42
◽
pp. 343
2021 ◽
Vol 103-B
(2)
◽
pp. 245-246
1993 ◽
Vol 53
(5)
◽
pp. 307-311
◽
Keyword(s):
2017 ◽
Vol 47
(11)
◽
pp. 3520-3540
◽